BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28197783)

  • 1. Freezing Nitrogen Ethanol Composite May be a Viable Approach for Cryotherapy of Human Giant Cell Tumor of Bone.
    Wu PK; Chen CF; Wang JY; Chen PC; Chang MC; Hung SC; Chen WM
    Clin Orthop Relat Res; 2017 Jun; 475(6):1650-1663. PubMed ID: 28197783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A safety comparative study between freezing nitrogen ethanol composite and liquid nitrogen for cryotherapy of musculoskeletal tumors.
    Chen CF; Chu HC; Chen CM; Cheng YC; Tsai SW; Chang MC; Chen WM; Wu PK
    Cryobiology; 2018 Aug; 83():34-39. PubMed ID: 29953845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative complications of using freezing nitrogen ethanol composite to treat bone tumors: Clinical experience from a single center.
    Chen YC; Chen CM; Chen KL; Wang PH; Chen CF; Wu PK; Chen WM
    J Chin Med Assoc; 2024 Jan; 87(1):64-69. PubMed ID: 37962122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
    Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
    Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
    Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryosurgery in the treatment of giant cell tumor. A long-term followup study.
    Malawer MM; Bickels J; Meller I; Buch RG; Henshaw RM; Kollender Y
    Clin Orthop Relat Res; 1999 Feb; (359):176-88. PubMed ID: 10078141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
    Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of benign giant cell tumours of bone in Singapore.
    Lim YW; Tan MH
    Ann Acad Med Singap; 2005 Apr; 34(3):235-7. PubMed ID: 15902343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.
    Benevenia J; Rivero SM; Moore J; Ippolito JA; Siegerman DA; Beebe KS; Patterson FR
    Clin Orthop Relat Res; 2017 Mar; 475(3):776-783. PubMed ID: 26932739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORR Insights
    Healey JH
    Clin Orthop Relat Res; 2017 Jun; 475(6):1664-1667. PubMed ID: 28243975
    [No Abstract]   [Full Text] [Related]  

  • 12. The effective distance and cooling rate of liquid nitrogen-based adjunctive cryotherapy for bone tumors ex vivo.
    Chang YC; Chao KY; Chen CM; Chen CF; Wu PK; Chen WM
    J Chin Med Assoc; 2022 Aug; 85(8):866-873. PubMed ID: 35666598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
    Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
    Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar local control between phenol- and ethanol-treated giant cell tumors of bone.
    Lin WH; Lan TY; Chen CY; Wu K; Yang RS
    Clin Orthop Relat Res; 2011 Nov; 469(11):3200-8. PubMed ID: 21732023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two devices for the treatment of keloid scars with the use of intralesional cryotherapy: An experimental study.
    van Leeuwen MC; Bulstra AE; van der Veen AJ; Bloem WB; van Leeuwen PA; Niessen FB
    Cryobiology; 2015 Aug; 71(1):146-50. PubMed ID: 25920961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
    Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
    World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision.
    Marcove RC; Sheth DS; Brien EW; Huvos AG; Healey JH
    Cancer; 1994 Aug; 74(4):1253-60. PubMed ID: 8055446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors related to biologic behavior in giant cell tumor of bone].
    Ran XY; Huang J; Zhang HZ; Jiang ZM; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):669-74. PubMed ID: 24433729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.